2026-05322
Proposed RuleEffective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis
Introduced: March 18, 2026
Progress
Summary
The Food and Drug Administration (FDA) is proposing to require the filing of a premarket approval application (PMA) for blood irradiators intended to irradiate intraoperatively salvaged blood for cancer patients undergoing surgery to assist in prevention of metastasis, which are unclassified, preamendments devices. FDA is summarizing its proposed findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet PMA requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the benefits to the public from use of the devices.
How This Affects You
Related Bills
HR 8052
To amend title 38, United States Code, to require that a sterile processing technician of the Veterans Health Administration holds an appropriate professional certification, and for other purposes
S 921
Tyler’s Law
HR 8043
To amend title 38, United States Code, to improve the efficiency of the recovery and collection of revenue for the Department of Veterans Affairs Medical Care Collections Fund, and for other purposes
HR 8067
To direct the Secretary of Health and Human Services to carry out a program under which the Secretary will collect data with respect to sickle cell disease in the United States, and for other purposes
S 864
HELP Copays Act
Get personalized insights on this bill
CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.